Skip to main content
. 2021 Dec 9;16(1):17–22. doi: 10.1177/1753495X211064458

Table 1.

Comparisons of demographics, hospital outcomes and costs for admissions with completed pregnancies for the moderate congenital heart disease (CHD), severe CHD and No CHD groups.

Factor Moderate CHD (n = 1277) OR for Moderate CHD vs No CHD (95% CI) Severe CHD (n = 251) OR for Severe CHD vs No CHD (95% CI) OR for Moderate CHD vs Severe CHD (95% CI) No CHD (n = 2,467,589) p
Age (y) 28.2 ± 5.8* 28.3 ± 5.5* 29.6 ± 5.8 <0.001
Age categories (n, %)
 15–19 80 (6.3) 9 (3.6) 105,302 (4.3) <0.001
 20–24 283 (22.2) 57 (22.7) 412,738 (16.7)
 25–29 404 (31.6) 85 (33.9) 673,756 (27.3)
 30–34 302 (23.6) 66 (26.3) 761,722 (30.9)
 35–39 178 (13.9) 27 (10.8) 421,455 (17.1)
 40–44 30 (2.3) 7 (2.8) 92,616 (3.8)
Race/Ethnicity (n, %)
 White 836 (65.5)* 177 (70.5)* 1,431,615 (58) <0.001
 Black 177 (13.9)* 25 (10)* 456,767 (18.5)
 Hispanic 210 (16.4) 30 (12) 442,597 (17.9)
 Asian/Pacific Islander 37 (2.9)* 8 (3.2) 146,993 (6)
Insurance (n, %)
 Private 611 (47.8)* 121 (48.2) 1,322,340 (53.6) <0.001
 Medicaid 602 (47.1)* 105 (41.8) 1,022,174 (41.4)
 Medicare 28 (2.2)* 8 (3.2)* 14,336 (0.6)
 Self-pay 6 (0.5)* 3 (1.2) 30,115 (1.2)
LOS (d) 4.4 ± 5.9* 6.6 ± 10.0*, 3.0 ± 2.8 <0.001
ICU admission (%) 8.9* 16.2 (13.4–19.7) 19.1*, 39.2 (28.6–53.7) 2.4 (1.7–3.5) 0.6 <0.001
Complications (n, %) 141 (11)* 1.3 (1.1–1.6) 37 (14.7)* 1.8 (1.3–2.6) 1.4 (0.9–2.1) 212,942 (8.6) <0.001
In-hospital mortality (n, %) 2 (0.16)* 17.9 (4.4–72.2) 2 (0.8)* 91.8 (22.7–371.3) 5.1 (0.7–36.5) 216 (0.01) <0.001
Total costs ($) $6391 ± 15,430* $10,929 ± 35,143*, $3672 ± 3196 <0.001

Post-hoc analyses: Age: Moderate CHD vs Severe CHD p = 0.9662, Moderate CHD vs No CHD p < 0.001, Severe CHD vs No CHD p = 0.001. Race: White race/ethnicity – No CHD vs Moderate CHD p < 0.001 and No CHD vs Severe CHD p < 0.001. Black race/ethnicity – No CHD vs Moderate CHD p < 0.001, No CHD vs. Severe CHD p = 0.004. Asian race/ethnicity – No CHD vs Moderate CHD p < 0.001. Insurance: Private – No CHD vs Moderate CHD p < 0.001. Medicaid – No CHD vs Moderate CHD p < 0.001. Medicare – No CHD vs Moderate CHD p < 0.001, No CHD vs Severe CHD p < 0.001. Self-pay – No CHD vs Moderate CHD p = 0.041. LOS: p < 0.001 for No CHD vs Moderate CHD, No CHD vs Severe CHD and Moderate CHD vs Severe CHD. ICU: No CHD vs Moderate CHD p < 0.001, No CHD vs Severe CHD p < 0.001, Moderate CHD vs Severe CHD p < 0.001. Complications: No CHD vs Moderate CHD p = 0.006, No CHD vs Severe CHD p = 0.002. In-hospital mortality: No CHD vs Moderate CHD p < 0.001, No CHD vs Severe CHD p < 0.001. Total costs: p < 0.001 for No CHD vs Moderate CHD, No CHD vs Severe CHD and Moderate CHD vs Severe CHD.

p Values are for comparison across all three groups with details of post-hoc analyses shown below the Table; * p ≤ 0.05 compared to No CHD, p ≤ 0.05 compared to Moderate CHD. Data are presented as n, %, mean ± standard deviation or odds ratio (95% confidence interval). Complications = higher presence of complications listed in the Vizient Clinical Data Base; ICU = intensive care unit; LOS = length of stay, OR = odds ratio. Data from the Vizient Clinical Data Base/Resource Manager used by permission of Vizient. All rights reserved.